NCT00108108 - Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG

HCD122

Trial Locations (5)

The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Div Of HematologicMalignancies, Baltimore

OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101, Columbus

St. Francis Cancer Research Foundation, Beech Grove

University of California San Diego StudyCoordinator:CHCD122A2101, La Jolla

MD Anderson Cancer Center/University of Texas Dept of MD Anderson CancerCent, Houston